New obesity injection tested for safety and weight loss
Disease control
Completed
This early-stage study tested a new injection called PB-119 in Chinese adults with obesity. The main goal was to check if the injection was safe and how the body processed it. Researchers also looked to see if it helped people lose weight over a 20-week treatment period.
Phase: PHASE1, PHASE2 • Sponsor: PegBio Co., Ltd. • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC